Shandong Boan Biotechnology Co., Ltd. (FRA:UJ9)

Market Cap	648.71M
Revenue (ttm)	89.95M
Net Income (ttm)	3.81M
Shares Out	n/a
EPS (ttm)	0.01
PE Ratio	170.39
Forward PE	38.27
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.9550
Previous Close	0.9850
Day's Range	0.9550 - 0.9550
52-Week Range	0.8700 - 2.1200
Beta	n/a
RSI	32.78
Earnings Date	Nov 27, 2025

About FRA:UJ9

Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China. The company offers Boyounuo (BA1101), an anti-VEGF humanized monoclonal antibody injection for mCRC, advanced metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, epithelial ovarian, fallopian tube, primary peritoneal cancer, cervical cancer, and hepatocellular carcinoma indications; Boyoubei (BA6101), a human immunoglobulin G2 monoclonal antibody of the RANK ligand for the treatment of post...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2013
• Employees: 760
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: UJ9

Financial Performance

Financial numbers in CNY